Healthcare

Mohammad Anas Wahaj | 13 jul 2013

Global healthcare supply chains - that include manufacturers, wholesalers, distributors, group purchasing organizations, healthcare providers - are facing enormous challenges due to the issues like counterfeiting, ineffective product recall and medication errors. According to McKinsey report, significant benefits in patient safety and savings in healthcare costs can be achieved by using and implementing a single unified global healthcare standard (Could save 22,000 - 43,000 lives and avert 0.7 to 1.4 million patient disabilities; Can keep billions of dollars of conterfeit drugs out of the legitimate supply chain; Safety benefits resulting in reduced healthcare costs by US$ 40-100 billion). Global healthcare leaders - manufacturers, distributors and hospitals - are embracing, endorsing and advocating the GS1 System of Standards that intends to maximise patient safety, optimise supply chain efficiency and minimise costs for all supply chain stakeholders. Read on...

Ferret: More than 30 global healthcare leaders endorse GS1 Healthcare Standards
Author: NA

Mohammad Anas Wahaj | 12 jul 2013

Professor John Rogers of Materials Science & Engineering at University of Illinois and his team is successfully exploring the possibilities in healthcare by fabricating devices from highly adaptive and sophisticated materials that could perform as electronic enhancements (with continuous and minimal intervention) to manage proper functioning of human body organs. Moreover he expects these designs and inventions to enable surgeons to use their fingertips as instruments; treat patients with implants that dissolve in human body after performing their work; electronic sutures that monitor surgical wounds for infection and healing; electronic tattoos on anywhere in the body to track blood flow and hydration and many more. Read on...

Illinois Alumni Magazine: Mind-bending electronics from the lab of UI scientist John Rogers promise to revolutionize health care in the plugged-in world of tomorrow
Author: Jim McFarlin

Mohammad Anas Wahaj | 08 jul 2013

Research shows that architectural design of mental health institutions that provides less noise, more open spaces and patient freedom - calm environment with home-like space - is capable of reducing aggression among patients. According to Professor of architecture, Dr. Roger S. Ulrich of Chalmers University of Technology in Sweden, reduction of trauma in healthcare facilities, in addition to improving lives of healthcare workers and patients also lowers the cost of care. Although the cost of construction of such facilities is higher but this is neutralized by savings in cost incurred in providing additional medical care or expensive lawsuits that can result from violent accidents. Read on...

Design Build Source: Design Can Reduce Aggression in Mental Health Facilities
Author: NA

Mohammad Anas Wahaj | 04 jul 2013

Research collaboration between scientists, Dr. Tak Mak of Canada and Dr. Dennis Slamon of US, is leading to the possibility of a 'sharp shooter' cancer drug that would be capable of halting the growth of various cancers. Scientists have recently filed for obtaining permission for human trials. The drug targets the specific enzyme that is a catalyst in cancerous cell division. Scientists say that if the trials are successful the drug will be available in the market in another 10 years. Read on...

Global News: A cancer breakthrough - Canada-U.S. team develop 'sharp-shooter' drug targeting several cancers
Author: Carmen Chai, Beatrice Politi

Mohammad Anas Wahaj | 03 jul 2013

Pharmaceutical industry has made heavy investments in the manufacture of biologic drugs like monoclonal antibodies, therapeutic proteins, immunotherapies and vaccines. The use of these drugs in treatment of many diseases will continue to increase and biologics sales are expected to reach US$ 166 billion by 2014. Moreover it is predicted that by 2023 biosimilar monoclonal antibodies and insulin products will account for 57% of the global biosimilars market. The technologies that are prevalent for manufacture of biopharmaceuticals traditionally include large fixed set-up with huge stainless steel bioreactors and tanks that are inflexible and require large capital expenditures. This is leading to their diminished utility in response to volume demand and changing market conditions. Now the production of personalized protein therapies will require changes in manufacturing technologies that would be more flexibile, low cost and can be produced in small batches. The need for multiproduct facilities will reduce use of larger equipments, large investments and facility installation times. Biopharma manufacturers are thus shifting to incorporate disposable or single use process technologies that result in smaller footprint, flexibility, scalability, and mobility without affecting product quality. Moreover single use bioreactors have other advantages like reduced cleaning and sterilization demands, cost savings of upto 60% as compared to fixed stainless steel bioreactors and are suitable for any type of biopharmaceutical product. Large therapeutic contract manufacturers are adopting this technology to produce biologics. The use of disposable technologies will further increase across the biopharmaceutical process and will globally improve healthcare options. Read on...

GEN: Flexibility in Biopharmaceutical Manufacturing Capacity
Author: Patricia Fitzpatrick Dimond

Mohammad Anas Wahaj | 05 jun 2013

Professor Philip Kotler defined marketing as 'exchange of value' and the concept is becoming more strengthened in the field of pharmaceutical marketing where 'value-based pricing' has reached a highly popular level. The language of customer needs is transforming itself into the language of value. As affordability is becoming an essential aspect of healthcare the customers are getting more focused on what value they can obtained from the pharma offerings. Marketing tools to attract customers will not work if the value to the customers lacks clarity. Pharma marketers have to plan and execute effectively their communication strategies to make customers understand value in the products that they are selling. Customized offerings would be an essential part of this process. Moreover pharma marketers have to think more closely into the patient treatment landscape and how it evolves in the future. Incorporating effective financial measures into a value proposition is a difficult task. Companies that focus on value and innovation and have integrated the concept of value in each and every aspect of the communication and planning process would be the ones that will succeed in the highly competitive pharma industry. Read on...

PMLive: Translating value in pharma marketing
Author: Jonathan Dancer

Mohammad Anas Wahaj | 03 jun 2013

Professor Atam Dhawan of NJIT is globally advocating for adoption of 'Point-of-Care Healthcare'. He suggests the importance of the concept by pointing out that it can reduce illness, improve the quality of life, and reduces the ever increasing healthcare costs. Wearable and home use medical devices with mobile technologies; use of big data such as electronic health records and patient-centric information from genome to physiom level; use of stem cells and regenerative medicine, tissue engineering and organ implants; surgical robotics etc are all technological innovations and advances alongwith communication and information systems that have the potential to transform healthcare delivery and enhance its quality with minimizing costs. Read on...

EurekAlert: Worldwide lecture tour touts point-of-care health care
Author: Sheryl Weinstein

Mohammad Anas Wahaj | 18 may 2013

A healthcare system in US is proposing three steps for accountability in healthcare. (1) Partnering with patients and families to make decisions- facilitates improvements and redesign in the healthcare delivery. (2) Connecting with patients before, after and between visits to the doctor- makes patient visits more productive and valuable. (3) Taking a broader view of the health of communities- by sharing health knowledge through community engagement programs. To become more accountable in delivering healthcare, partnerships between professionals, patients, families and communities are essential. Read on...

HealthCanal: Becoming More Accountable - Three Ways Health Care is Changing
Author: NA

Mohammad Anas Wahaj | 25 apr 2013

Best practices and improvements in one industry can influence and transform the practices in the others. According to researchers, healthcare supply chain can benefit considerably by adopting the best practices and advances in the retail supply chain management. Experts suggest 10 best practices from retail supply chain management that can transform healthcare supply chain- Collaborative Planning; Forecasting and Replenishment; Scanning Technology; Education and Training; Centralized Purchasing and Supply; Supply Chain Services Reorganization; Regular Cycle Counting and Stock Rotation; Performance Management; Actual Usage Inventory Management; Ecommerce; Data Standardization. Read on...

Healthcare Global: Health Supply Chains Improve Using Retail Best Practice
Author: Abigail Phillips

Mohammad Anas Wahaj | 11 apr 2013

Medical robotics has the potential to transform the future of healthcare. Although less than 2 percent of surgical procedures are performed robotically, but surgical robots enhance surgeon's skills by providing 3D visualizations, minimally invasive incisions etc. They also prevent human surgeons from getting exposed during radiation emitting fluoroscopy procedures. Moreover, robots are also being used to perform routine nursing related jobs in day to day patient care activities. They may also be able to reduce human errors, that are a major issue in hospitals. But large scale adoption of robotics technologies in the healthcare industry will still take some time. Read on...

Healthcare Global: Robotics and Health Care
Author: Emily Couch

Latest             ⊲ Newer Posts             Healthcare             Older Posts ⊳             Last